DCM
SGYP

DAFNA Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

DAFNA Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-34,000
Closed -$207K – 81
2016
Q4 		$207K Sell
34,000
-240,563
-88% -$1.26M 0.18% 62
2016
Q3 		$1.51M Sell
274,563
-45,000
-14% -$211K 1.05% 34
2016
Q2 		$1.21M Buy
319,563
+25,000
+8% +$84.7K 0.96% 37
2016
Q1 		$813K Hold
294,563
– – 0.7% 41
2015
Q4 		$1.67M Sell
294,563
-2,000
-0.7% -$12.2K 1.49% 20
2015
Q3 		$1.57M Sell
296,563
-21,000
-7% -$163K 1.56% 19
2015
Q2 		$2.64M Buy
+317,563
New +$1.54M 2.23% 14

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return